Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norio Watanabe

Showing results (81-90 of 160) with videos related to

Pageof 16
Sort By:
Child and Adolescent Psychiatry and Mental Health|November 23, 2019
Developing the universal unified prevention program for diverse disorders for school-aged childrenShin-Ichi Ishikawa, Kohei Kishida, Takuya Oka, et al.
The Cochrane Database of Systematic Reviews|March 19, 2010
Fluvoxamine versus other anti-depressive agents for depressionIchiro M Omori, Norio Watanabe, Atsuo Nakagawa, et al.
Psychiatry and Clinical Neurosciences|September 11, 2014
Cost-effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trialNorio Watanabe, Toshiaki A Furukawa, Shinji Shimodera, et al.
Neuropsychopharmacology Reports|July 20, 2022
Comparison of the efficacy and safety of quetiapine and lithium for bipolar depression: A systematic review and meta-analysis of randomized controlled trialsMasaya Ogasawara, Masahiro Takeshima, Yuichi Esaki, et al.
CNS Drugs|December 25, 2009
Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysisNorio Watanabe, Ichiro M Omori, Atsuo Nakagawa, et al.
The Cochrane Database of Systematic Reviews|July 10, 2009
Milnacipran versus other antidepressive agents for depressionAtsuo Nakagawa, Norio Watanabe, Ichiro M Omori, et al.
Trials|August 14, 2014
Multifamily psychoeducation for improvement of mental health among relatives of patients with major depressive disorder lasting more than one year: study protocol for a randomized controlled trialFujika Katsuki, Hiroshi Takeuchi, Norio Watanabe, et al.
The Journal of Clinical Psychiatry|February 6, 2009
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysisNorio Watanabe, Ichiro M Omori, Atsuo Nakagawa, et al.
BMC Public Health|June 26, 2024
National burden of gambling in Japan: an estimation from an online-based cross-sectional investigation and national epidemiological surveyChiyoung Hwang, Ryuhei So, Nozomu Hashimoto, et al.
CNS Drugs|June 13, 2008
Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysisAtsuo Nakagawa, Norio Watanabe, Ichiro M Omori, et al.
Pageof 16

Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
Child and Adolescent Psychiatry and Mental Health|November 23, 2019
Developing the universal unified prevention program for diverse disorders for school-aged childrenShin-Ichi Ishikawa, Kohei Kishida, Takuya Oka, et al.
The Cochrane Database of Systematic Reviews|March 19, 2010
Fluvoxamine versus other anti-depressive agents for depressionIchiro M Omori, Norio Watanabe, Atsuo Nakagawa, et al.
Psychiatry and Clinical Neurosciences|September 11, 2014
Cost-effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trialNorio Watanabe, Toshiaki A Furukawa, Shinji Shimodera, et al.
Neuropsychopharmacology Reports|July 20, 2022
Comparison of the efficacy and safety of quetiapine and lithium for bipolar depression: A systematic review and meta-analysis of randomized controlled trialsMasaya Ogasawara, Masahiro Takeshima, Yuichi Esaki, et al.
CNS Drugs|December 25, 2009
Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysisNorio Watanabe, Ichiro M Omori, Atsuo Nakagawa, et al.
The Cochrane Database of Systematic Reviews|July 10, 2009
Milnacipran versus other antidepressive agents for depressionAtsuo Nakagawa, Norio Watanabe, Ichiro M Omori, et al.
Trials|August 14, 2014
Multifamily psychoeducation for improvement of mental health among relatives of patients with major depressive disorder lasting more than one year: study protocol for a randomized controlled trialFujika Katsuki, Hiroshi Takeuchi, Norio Watanabe, et al.
The Journal of Clinical Psychiatry|February 6, 2009
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysisNorio Watanabe, Ichiro M Omori, Atsuo Nakagawa, et al.
BMC Public Health|June 26, 2024
National burden of gambling in Japan: an estimation from an online-based cross-sectional investigation and national epidemiological surveyChiyoung Hwang, Ryuhei So, Nozomu Hashimoto, et al.
CNS Drugs|June 13, 2008
Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysisAtsuo Nakagawa, Norio Watanabe, Ichiro M Omori, et al.
Pageof 16